Aims and Scope of Annals of Pharmacotherapy
The Annals of Pharmacotherapy is a peer-reviewed medical journal covering all aspects of pharmacotherapy. The journal was established in 1967 as Drug Intelligence. The name changed a few times during its history, to Drug Intelligence and Clinical Pharmacy (DICP) in 1969 and DICP-The Annals of Pharmacotherapy in 1989, before obtaining its current name in 1992. Less
Key Metrics
CiteScore 

5
H-Index 

120
Impact Factor 

< 5
SJR 

Q1Pharmacology (medical)

SNIP 

1.15
Recommended pre-submission checks
Powered by 

Topics Covered on Annals of Pharmacotherapy
Annals of Pharmacotherapy Journal Specifications
| Overview | |
| Publisher | SAGE PUBLICATIONS INC |
| Language | Multi-Language |
| Frequency | Monthly |
| General Details | |
| Language | Multi-Language |
| Frequency | Monthly |
| Publication Start Year | 1967 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Annals of Pharmacotherapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Annals of Pharmacotherapy
Evaluation of a Pharmacist-Led Intravenous Iron Therapy Transitions of Care Service in Heart Failure.
- 1 Jun 2026
- The Annals of pharmacotherapy
Newly Escalated Psychotropic Medications in the Trauma Intensive Care Unit: Prescribing Patterns During Care Transitions.
- 1 Jun 2026
- The Annals of pharmacotherapy
Evaluation of Nurse-Managed Heparin Nomogram Adherence After Implementation of an Electronic Health Record-Embedded Heparin Calculator: An Antithrombotic Stewardship Initiative.
- 1 Jun 2026
- The Annals of pharmacotherapy
Relieving the Weight: Fenfluramine's Re-emergence as Antiseizure Medication for Lennox-Gastaut and Dravet Syndrome.
- 1 Jun 2026
- The Annals of pharmacotherapy
Assessment of Guideline-Directed Medical Therapy Optimization Scores and Readmission Risk in Heart Failure With Reduced Ejection Fraction.
- 1 Jun 2026
- The Annals of pharmacotherapy
Pyzchiva (ustekinumab-ttwe): A New Biosimilar for Psoriasis.
- 1 Jun 2026
- The Annals of pharmacotherapy
Evaluation of a Pharmacist-Led Intravenous Iron Therapy Transitions of Care Service in Heart Failure.
- 1 Jun 2026
- The Annals of pharmacotherapy
Newly Escalated Psychotropic Medications in the Trauma Intensive Care Unit: Prescribing Patterns During Care Transitions.
- 1 Jun 2026
- The Annals of pharmacotherapy
Evaluation of Nurse-Managed Heparin Nomogram Adherence After Implementation of an Electronic Health Record-Embedded Heparin Calculator: An Antithrombotic Stewardship Initiative.
- 1 Jun 2026
- The Annals of pharmacotherapy
Relieving the Weight: Fenfluramine's Re-emergence as Antiseizure Medication for Lennox-Gastaut and Dravet Syndrome.
- 1 Jun 2026
- The Annals of pharmacotherapy
Assessment of Guideline-Directed Medical Therapy Optimization Scores and Readmission Risk in Heart Failure With Reduced Ejection Fraction.
- 1 Jun 2026
- The Annals of pharmacotherapy
Pyzchiva (ustekinumab-ttwe): A New Biosimilar for Psoriasis.
- 1 Jun 2026
- The Annals of pharmacotherapy